Establishment and characterization of a new synovial sarcoma cell line, SN-SY-1: Special reference to bcl-2 protein and SYT-SSX1 hybrid transcripts

International Journal of Cancer

Volumn 72, Issue 6, 1997, Pages 995-1002

  Noguchi, Shin Ichi ^a   Ueki, Takashi ^a   Kawauchi, Shigeto ^a   Fukuda, Toshiro ^a   Matsuura, Hiroshi ^b   Sonoda, Takashi ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAISEIKAI FUKUOKA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL POPULATION; CELL SHAPE; CHROMOSOME ANALYSIS; DNA DETERMINATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SYNOVIAL SARCOMA;

ABDOMINAL NEOPLASMS; ADULT; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENES, BCL-2; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; PROTEIN HYBRIDIZATION; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SARCOMA, SYNOVIAL; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; X CHROMOSOME;

EID: 0030864083     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970917)72:6<995::AID-IJC13>3.0.CO;2-4     Document Type: Article

References (47)

1. ALVAREZ-FERNANDEZ, E. and ESCALONA-ZAPATA, J., Monophasic mesenchymal synovial sarcoma: its identification by tissue culture. Cancer, 47, 628-635 (1981).
2. BISSONNETTE, R.P., ECHEVERRI, F., MAHBOUBI, A. and GREEN, D.R., Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (Lond.), 359, 552-554 (1992).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
4. CLARK, J., ROCQUES, P.J., CREW, A.J., GILL, S., SHIPLEY, J., CHAN, A.M.L., GUSTERSON, B.A. and COOPER, C.S., Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nature (Genet.), 7, 502-508 (1994).
5. CORDON-CARDO, C. and RICHON, V.M., Expression of the retinoblastoma protein is regulated in normal human tissues. Amer. J. Pathol., 144, 500-510 (1994).
6. CREW, A.J., CLARK, J., FISHER, C., GILL, S., GRIMER, R., CHAND, A., SHIPLEY, J., GUSTERSON, B.A. and COOPER, C.S., Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J., 14, 2333-2340 (1995).
7. DE LEEUW, B., BALEMANS, M. and GEURTS VAN KESSEL, A., A novel Kruppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet. Cell Genet., 73, 179-183 (1996).
8. DE LEEUW, B., BALEMANS, M., OLDE WEGHUIS, D., SERUCA, R., JANZ, M., GERAGHTY, M.T., GILGENKRANZ, S., ROPERS, H.H. and GEURTS VAN KESSEL, A., Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2;q11.2) breakpoint. Hum. Mol. Genet., 3, 745-749 (1994a).
9. DE LEEUW, B., SUIJKERBUIJK, R.F., OLDE WEGHUIS, D., MELONI, A.M., STENMAN, G., KINDBLOM, L.G., BALEMANS, M., VANDENBERG, E., MOLENAAR, W.M., SANDBERG, A.A. and GEURTS VAN KESSEL, A., Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet. Cytogenet., 73, 89-94 (1994b).
10. DOLE, M., NUNEZ, G., MERCHANT, A.K., MAYBAUM, J., RODE, C.K., BLOCH, C.A. and CASTLE, V.P., bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 54, 3253-3259 (1994).
11. END, D. and GARRABRANT, T., Characterization of a high affinity interleukin-1 (IL-1) specific binding site in a human synovial sarcoma (Hs431) cell line. Lymphokine Res., 9, 167-176 (1990).
12. ENZINGER, F.M. and WEIS, S.W., Synovial sarcoma. In: F.M. Enzinger and S.W. Weiss (eds.), Soft tissue tumors (3rd ed.), pp. 757-786, Mosby, St. Louis (1995).
13. ESUMI, N., IMASHUKU, S., TSUNAMOTO, K., TODA, S., MISAWA, S., GOTO, T. and FUJISAWA, Y., Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation, and cytogenetic abnormality. Jpn. J. Cancer, 48, 194-198 (1989).
14. FEINBERG, A.P. and VOGELSTEIN, B., A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13 (1983).
15. HENNET, T., BERTONI, G., RICHTER, C. and PETERHANS, E., Expression of bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res., 53, 1456-1460 (1993).
16. HIRAKAWA, N., NAKA, T., YAMAMOTO, I., FUKUDA, T. and TSUNEYOSHI, M., The overexpression of bcl-2 protein in synovial sarcoma - with a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum. Pathol., 27, 1060-1065 (1996).
17. HOCKENBERY, D. M., ZUTTER, M., HICKEY, W., NAHM, M. and KORSMEYER, S.J., Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. nat. Acad. Sci. (Wash.), 88, 6961-6965 (1991).
18. KNIGHT, J.C., REEVES, B.R., KEAMEY, L., MONACO, A.P., LEHRACH, H. and COOPER, C.S., Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization. Hum. mol. Genet., 8, 633-637 (1992).
19. KRAJEWSKI, S., CHATTEN, J., HANADA, M. and REED, J.C., Immunohistochemical analysis of the bcl-2 oncoprotein in human neuroblastomas: comparisons with tumor cell differentiation and N-myc protein. Lab. Invest., 71, 42-54 (1995).
20. LEEK, R.D., KAKLAMANIS, L., PEZZELA, F., GATTER, K.C. and HARRIS, A.L., Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer. 69, 135-139 (1994).
21. LIANG, X.H., MUNGAL, S., AYSCUE, A., MEISSNER, J.D., WODNICKI, P., HOCKENBERY, D., LOCKETT, S. and HERMAN, B., bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J. Cell. Biochem., 57, 509-521 (1995).
22. LOTEM, J., and SACHS, L., Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ., 4, 41-47 (1993).
23. LU, Q.-L., POULSOM, R., WONG, L. and HANDY, A.M., Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol., 169, 431-437 (1993).
24. MCDONNELL, T.J., TRONCOSO, P., BRISBAY, S.M., LOGOTHETIS, C., CHUNG, L.W.K., HSIEH, J., TU, S. and CAMPBELL, M.L., Expression of protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
25. MEIS-KINDBLOM, J.M., KINDBLOM, L.G. and ENZINGER, F.M., Sclerosing epithelioid fibrosarcoma: a variant of fibrosarcoma simulating carcinoma. Amer. J. surg. Pathol., 19, 979-993 (1995).
26. NOJIMA, T., WANG, Y.S., ABE, S., MATSUNO, T., YAMAWAKI, S. and NAGASHIMA, K., Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol. Jpn., 40, 486-493 (1990).
27. ORDONEZ, N.G., MAHFOUZ, S.M. and MACKAY, B., Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum. Pathol., 21, 733-749 (1990).
28. PEZZELLA, F., TSE, A.G., CORDELL, J.L., PULFORD, K.A., GATTER, K.C. and MASON, D.Y., Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Amer. J. Pathol. 137, 225-232 (1990).
29. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.F., DUNNILL, M.S., PIERCE, C.B., HARRIS, A., GATTER, K.C. and MASON, D.Y., bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med. 329, 690-694 (1993).
30. PONTÉN, J. and SAKSELA, E., Two established in vitro cell lines from human mesenchymal tumors. Int. J. Cancer. 2, 434-447 (1967).
31. REED, J.C., Bcl-2 and the regulation of programmed cell death (review). J. Cell Biol., 124, 1-6 (1994).
32. REED, J.C., TSUJIMOTO, Y., ALPERS, J.D., CROCE, C.M. and NOWELL, P.C., Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science, 236, 1295-1299 (1987).
33. REEVES, B.R., SMITH, S., FISHER, C., WARREN, W., KNIGHT, J., MARTIN, C., CHAN, A.M.L., GUSTERSON, B.A., WESTBURY, G. and COOPER, C.S., Characterization of the translocation between chromosomes X and 18 in human synovial sarcomas. Oncogene, 4, 373-378 (1989).
34. RENWICK, P.J., REEVES, B.R., CIN, P.D., FLETCHER, C.D.M., KEMPSKI, H., SCIOT, R., KAZMIERCZAK, B., JANI, K., SONOBE, H. and KNIGHT, J.C., Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for histologic subclassification of synovial sarcoma. Cytogenet. Cell Genet., 70, 58-63 (1995).
35. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual (2nd ed.), Cold Spring Harbor, New York (1989).
36. RB)) in osteosarcomas and synovial sarcomas. Oncogene Res., 1, 205-214 (1989).
37. SINGLETARY, S.E., WILLIAMS, N.N., RODECK, U., LARRY, L., TUCKER, S., SPITZER, G. and HERLYN, M., Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. Anticancer Res., 10, 1501-1506 (1990).
38. SONOBE, H., MANABE, Y., FURIHATA, M., IWATA, J., OKA, T., OUTSUKI, Y., MIZOBUCHI, H., YAMAMOTO, H., KUMANO, O. and ABE, S., Establishment and characterization of a new human synovial sarcoma cell line. HS-SY-II. Lab. Invest., 67, 498-505 (1992).
39. SREEKANTAIAH, C., LADANYI, M., RODRIGUEZ, E. and CHAGANTI, R.S.K., Chromosomal aberrations in soft tissue tumors: relevance to diagnosis, classification and molecular mechanisms. Amer. J. Pathol., 144, 1121-1133 (1994).
40. TSUJIMOTO, Y., Stress-resistance conferred by high level of bcl-2 alpha protein in human B-lymphoblastoid cells. Oncogene, 4, 1331-1336 (1989).
41. TSUJIMOTO, Y., GORHAM, J., COSSMAN, J., JAFFE, E. and CROCE, C.M., The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 229, 1390-1393 (1985).
42. TURC-CAREL, C., DAL CIN, P., LIMON, J., LI, F. and SANDBERG, A.A., Translocation X;18 in synovial sarcoma. Cancer Genet. Cytogenet., 23, 93 (1986).
43. VAUX, D.L., Toward an understanding of the molecular mechanisms of physiological cell death. Proc. nat. Acad. Sci. (Wash.), 90, 786-789 (1993).
44. VAUX, D.L., CORY, S. and ADAMS, J.M., bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335, 440-442 (1988).
45. WEISS, S.W. (ed.), Histopathological typing of soft tissue tumors (2nd ed.). In: International Histopathological Classification of tumors. World Health Organization, Geneva (1994).
46. WILLIAMS, G.T. and SMITH, C.A., Molecular regulation of apoptosis: genetic controls on cell death. Cell. 74, 777-779 (1993).
47. XU, H.-J., HU, S.-X., CAGLE, P.T., MOORE, G.E. and BENEDICT, W.F., Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res., 51, 2735-2739 (1991).